Skip to main content

Table 4 Adjusted prevalence ratios of cardiovascular risk (≥15%) associated with serum 25(OH)D by age, NHANES 2001–2010

From: Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001–2010

    CVD risk (≥15%)
Serum 25(OH)D quartiles
(nmol/L)
Q1 (<43.4) Q2 (43.4–58.6) Q3 (58.7–74.2) Q4 (≥74.3)
Overall 20–59 (y) Ref 0.78 0.60, 1.02 0.93 0.70, 1.23 0.65* 0.47, 0.92
≥60 (y) Ref 0.99 0.89, 1.09 0.89* 0.80, 0.99 0.82* 0.73, 0.92
a Mexican Americans 20–59 (y) Ref 0.70 0.49, 1.01 0.80 0.50, 1.27 0.75 0.44, 1.29
≥60 (y) Ref 0.93 0.79, 1.10 0.92 0.78, 1.08 0.81 0.63, 1.03
a Non-Hispanic Whites 20–59 (y) Ref 0.70 0.48, 1.02 0.89 0.62, 1.29 0.61* 0.40, 0.93
≥60 (y) Ref 1.01 0.88, 1.16 0.90 0.79, 1.04 0.82* 0.74, 0.97
a Non-Hispanic Blacks 20–59 (y) Ref 1.03 0.75, 1.43 0.97 0.69, 1.37 0.51 0.19, 1.40
≥60 (y) Ref 0.88 0.75, 1.04 0.86 0.71, 1.04 0.63* 0.45, 0.88
  1. Models are adjusted for age, sex, education, ethnicity, season of blood draw, survey cycle, smoking, BMI, total physical activity
  2. vitamin D supplement use, and lipid and anti-hyperglycemic medications. * P < 0.05
  3. a The ethnicity covariate is excluded in the ethnic-specific models